1. Home
  2. GKOS vs FLR Comparison

GKOS vs FLR Comparison

Compare GKOS & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.56

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Fluor Corporation

FLR

Fluor Corporation

HOLD

Current Price

$49.41

Market Cap

6.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
FLR
Founded
1998
1912
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.7B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
GKOS
FLR
Price
$116.56
$49.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
6
Target Price
$133.07
$53.50
AVG Volume (30 Days)
661.7K
2.3M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
$15,503,000,000.00
Revenue This Year
$23.30
$6.15
Revenue Next Year
$27.43
$7.31
P/E Ratio
N/A
N/A
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$32.45
52 Week High
$130.23
$57.50

Technical Indicators

Market Signals
Indicator
GKOS
FLR
Relative Strength Index (RSI) 58.27 57.86
Support Level $104.72 $43.20
Resistance Level $123.16 $52.05
Average True Range (ATR) 4.70 1.65
MACD 1.71 0.42
Stochastic Oscillator 69.51 78.83

Price Performance

Historical Comparison
GKOS
FLR

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About FLR Fluor Corporation

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $15.5 billion in revenue in 2025.

Share on Social Networks: